LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
BT-20 Radicicol
3.33
uM
LJP6
 72
hr
 1097 1007 3673 0.2743 -0.0480
BT-20 Radicicol
10
uM
LJP5
 72
hr
 1097 704 3846 0.1827 -0.2196
BT-20 Radicicol
10
uM
LJP6
 72
hr
 1097 595 3673 0.1621 -0.2958
BT-20 Withaferin A
0.04
uM
LJP5
 72
hr
 1097 4114 3846 1.0697 1.0755
BT-20 Withaferin A
0.04
uM
LJP6
 72
hr
 1097 3946 3673 1.0747 1.0842
BT-20 Withaferin A
0.12
uM
LJP5
 72
hr
 1097 4236 3846 1.1019 1.1104
BT-20 Withaferin A
0.12
uM
LJP6
 72
hr
 1097 3547 3673 0.9661 0.9603
BT-20 Withaferin A
0.37
uM
LJP5
 72
hr
 1097 2794 3846 0.7272 0.6771
BT-20 Withaferin A
0.37
uM
LJP6
 72
hr
 1097 2260 3673 0.6157 0.5139
BT-20 Withaferin A
1.11
uM
LJP5
 72
hr
 1097 990 3846 0.2576 -0.0553
BT-20 Withaferin A
1.11
uM
LJP6
 72
hr
 1097 900 3673 0.2450 -0.1075
BT-20 Withaferin A
3.33
uM
LJP5
 72
hr
 1097 568 3846 0.1480 -0.3047
BT-20 Withaferin A
3.33
uM
LJP6
 72
hr
 1097 535 3673 0.1458 -0.3376
BT-20 Withaferin A
10
uM
LJP5
 72
hr
 1097 615 3846 0.1601 -0.2739
BT-20 Withaferin A
10
uM
LJP6
 72
hr
 1097 566 3673 0.1542 -0.3158